Located in Boston and the surrounding communities, Dana-Farber Cancer Institute brings together world renowned clinicians, innovative researchers and dedicated professionals, allies in the common mission of conquering cancer, HIV/AIDS and related diseases. Combining extremely talented people with the best technologies in a genuinely positive environment, we provide compassionate and comprehensive care to patients of all ages; we conduct research that advances treatment; we educate tomorrow's physician/researchers; we reach out to underserved members of our community; and we work with amazing partners, including other Harvard Medical School-affiliated hospitals.
Dana-Farber Cancer Institute (DFCI) launched the Patient Reported Data (PRD) Program in 2016 to govern appropriate content, implementation and analysis of PRD. PRD is defined as “any report of the status of a patient’s health condition that comes directly from the patient, without interpretation of the patient’s response by a clinician or anyone else.” There is growing evidence supporting the use of PRD to improve processes of care and health services outcomes. Leveraging established survival benefits of direct patient report, we have begun to implement electronic collection of PRD at clinic visits across DFCI, increasing collection rates from <10% (patient portal) to nearly 70% for new patients and 98% for established patients (via mobile tablets), bypassing barriers of low patient portal enrollment (<40%) or lack of computer access (20%).
Over the next 3 years, the department of Informatics & Analytics, under the guidance of the PRD Advisory committee and in collaboration with Clinical Informatics, Clinical Operations, and Quality/Patient Safety, will further develop and expand the PRD program. This will include expanding the use of PRD across all institute floors and practice sites, developing PRD tools that are customized to each patient’s specific cancer/treatment, and demonstrating the impact/value of PRD for cancer care delivery and research. The roadmap includes refinement of current PRD projects, oversight of new PRD projects, and coordination of tablet/mobile device management. This is a significant initiative within DFCI, requiring coordination across multiple clinical, operations and research departments, as well as Partners HealthCare Information Systems (IS).
The initial focus of the Program Manager will center on project coordination and program structure. The program manager will be tasked with coordinating the implementation of 3-5 PRD applications, ensuring project deliverables and tasks are successfully completed on time, fostering a cohesive team environment and, as the representative of the PRD implementation, collaborating with all levels of staff including senior leadership. The Program Manager will also be expected to lead the creation of a program structure that adheres to a formal governance process. S/he will need direct, in-depth experience in developing solutions, leading programs at a multi-faceted healthcare organization, and managing complex client relationships. This position requires strong project management skills, exceptional customer service skills, and the ability to manage expectations of senior business leaders.
The position is currently funded for one year; renewal is anticipated depending on conditions at expiration.
Skills, Abilities, Competencies
Dana-Farber Cancer Institute is an equal opportunity employer and affirms the right of every qualified applicant to receive consideration for employment without regard to race, color, religion, sex, gender identity or expression, national origin, sexual orientation, genetic information, disability, age, ancestry, military service, protected veteran status, or other groups as protected by law.